Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
- PMID: 23943561
- PMCID: PMC3924023
- DOI: 10.1007/s12094-013-1077-2
Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
Abstract
Purpose: To estimate the cost per skeletal-related event (SRE) in patients with bone metastases secondary to solid tumours in the Spanish healthcare setting.
Methods: Patients diagnosed with bone metastases secondary to breast, prostate or lung cancer were included in this multicentre, observational study. SREs are defined as pathologic fracture (vertebral and non-vertebral fracture), radiation to bone, spinal cord compression or surgery to bone. Health resource utilisation associated with these events (inpatient stays, outpatient, emergency room and home health visits, nursing home stays and procedures) were collected retrospectively for all SREs that occurred in the 97 days prior to enrolment and prospectively during follow-up. Unit costs were obtained from the 2010 eSalud healthcare costs database.
Results: A total of 93 Spanish patients with solid tumours were included (31 had breast cancer, 21 prostate cancer and 41 lung cancer), contributing a total of 143 SREs to this cost analysis. Inpatient stays (between 9.0 and 29.9 days of mean length of stay per inpatient stay by SRE type) and outpatient visits (between 1.7 and 6.4 mean visits per SRE type) were the most frequently reported types of health resources utilised. The mean cost per SRE was between <euro>2,377.79 (radiation to bone) and <euro>7,902.62 (spinal cord compression).
Conclusion: SREs are associated with a significant consumption of healthcare resources that generate a substantial economic burden for the Spanish healthcare system.
Similar articles
-
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study.J Med Econ. 2013;16(5):691-700. doi: 10.3111/13696998.2013.779921. Epub 2013 Mar 15. J Med Econ. 2013. PMID: 23441975
-
Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.J Manag Care Pharm. 2010 Nov-Dec;16(9):693-702. doi: 10.18553/jmcp.2010.16.9.693. J Manag Care Pharm. 2010. PMID: 21067255 Free PMC article.
-
Health resource utilization associated with skeletal-related events: results from a retrospective European study.Eur J Health Econ. 2016 Jul;17(6):711-21. doi: 10.1007/s10198-015-0716-7. Epub 2015 Aug 8. Eur J Health Econ. 2016. PMID: 26253584 Free PMC article.
-
Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.Pharmacoeconomics. 2012 May;30(5):373-86. doi: 10.2165/11631390-000000000-00000. Pharmacoeconomics. 2012. PMID: 22500986 Review.
-
Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer.Curr Opin Oncol. 2014 May;26(3):274-83. doi: 10.1097/CCO.0000000000000071. Curr Opin Oncol. 2014. PMID: 24626126 Review.
Cited by
-
Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.Molecules. 2021 Apr 9;26(8):2162. doi: 10.3390/molecules26082162. Molecules. 2021. PMID: 33918705 Free PMC article. Review.
-
Non-cancer Causes of Death Following Initial Synchronous Bone Metastasis in Cancer Patients.Front Med (Lausanne). 2022 Jun 2;9:899544. doi: 10.3389/fmed.2022.899544. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35721072 Free PMC article.
-
Narrative review of the epidemiology, economic burden, and societal impact of metastatic bone disease.Ann Jt. 2022 Jul 15;7:28. doi: 10.21037/aoj-20-97. eCollection 2022. Ann Jt. 2022. PMID: 38529136 Free PMC article. Review.
-
Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.J Bone Oncol. 2016 Sep 12;5(4):185-193. doi: 10.1016/j.jbo.2016.07.003. eCollection 2016 Nov. J Bone Oncol. 2016. PMID: 28008381 Free PMC article.
-
SEOM Clinical Guideline for bone metastases from solid tumours (2016).Clin Transl Oncol. 2016 Dec;18(12):1243-1253. doi: 10.1007/s12094-016-1590-1. Epub 2016 Nov 28. Clin Transl Oncol. 2016. PMID: 27896639 Free PMC article.
References
-
- Delea T, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol. 2006;4(7):341–347. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical